✦ LIBER ✦

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

✍ Scribed by Uri Goldbourt; Solomon Behar; Henrietta Reicher-Reiss; Jacob Agmon; Elieser Kaplinsky; Eran Graft; Yehezkiel Kishon; Avraham Caspi; Joshua Weisbort; Lori Mandelzweig; Edward Abinader; Leon Aharon; Shimeon Braun; Daniel David; Michael Flich; Yaacov Friedman; Natalio Kristal; Noa Leil; Walter Markiewicz; Alon Marmor; Abraham Palant; Benjamin Pelled; Babeth Rabinowitz; Leornardo Reisin; Nathan Roguin; Tiberio Rosenfeld; Zwi Schlesinger; Samuel Sclarovsky; Libi Sherf; Daniel Tzivoni; Izhar Zahavi; Monty Zion; Daniel Brunner

Book ID: 113119162
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 888 KB
Volume: 71
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(93)90905-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relation of Clinical Benefit of Raising

Relation of Clinical Benefit of Raising High-Density Lipoprotein Cholesterol to Serum Levels of Low-Density Lipoprotein Cholesterol in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)

✍ Ilan Goldenberg; Michal Benderly; Roy Sidi; Valentina Boyko; Alexander Tenenbaum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Relation Between On-Treatment Increments

Relation Between On-Treatment Increments in Serum High-Density Lipoprotein Cholesterol Levels and Cardiac Mortality in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)

✍ Ilan Goldenberg; Uri Goldbourt; Valentina Boyko; Solomon Behar; Henrietta Reiche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Evaluation of a novel antiplatelet agent

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial

✍ David A. Morrow; Benjamin M. Scirica; Keith A.A. Fox; Gail Berman; John Strony; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 329 KB

The role of niacin in raising high-densi

The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH)

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 274 KB

The role of niacin in raising high-densi

The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 130 KB